ADS Diagnostic Board Meeting Notice for Q2 FY27 Results

ADS DIAGNOSTIC LIMITED

Nature of Disclosure: Regulatory filing with Bombay Stock Exchange providing notice of upcoming board meeting as required under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Board Meeting Details:

• Meeting scheduled for Thursday, 12th November, 2026
• Venue: Registered Office of the Company

Agenda Items:

1. Consideration and approval of Unaudited Financial Results for the quarter ended 30th September, 2026

2. Consideration of any other business with the permission of the chair

Regulatory Compliance:

• Filed under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• Addressed to The General Manager, Bombay Stock Exchange Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai, Maharashtra – 400 001

• Signed by N Lal Gayari (digitally signed as NARAYAN LAL GAYARI)
• Designation: CFO & Company Secretary
• Signing date: 2026.11.04 at 16:04:47 +05'30'

Financial Impact: Not quantified in the disclosure. The meeting agenda includes approval of financial results, but specific figures are not provided in this notice.